FDA De Novo granted · DEN250004

UV-C protection for every IV line. In 10 seconds.

QIKcap™ adds an automated UV-C cycle at the needleless connector after the CHG/IPA scrub, then caps it as a physical barrier for up to 7 days.

QIKcap handheld UV-C device held in a gloved hand QIKcap single-use caps with yellow and magenta dosimeter rings
FDA De Novo granted
Clinician-founded
U.S. patented technology
Independently tested in vitro

The problem

Every access is a chance for contamination.

Needleless connectors are accessed many times a day, and "scrub the hub" technique varies with workload, fatigue and urgency. The bloodstream infections that can follow are among the costliest hospital-acquired conditions, and CMS tracks them under its HAC Reduction Program.

$48,108

Estimated additional cost per CLABSI (AHRQ)

1 in 5

hospital-onset bacteremia events was an NHSN-reported CLABSI, so CLABSI rates alone miss most cases (CDC-led study, ICHE 2019)

How it works

Scrub it. Cap it. Zap it.™

Single-use QIKcap held in a gloved hand

01 · SCRUB

Scrub the hub

Follow the connector's instructions with a CHG/IPA wipe, such as QIKswab™.

QIKcap cap strip on an IV pole

02 · CAP

Apply the QIKcap

A sterile, single-use luer cap from the IV-pole strip seals the connector.

QIKcap handheld device

03 · ZAP

10-second UV-C cycle

The device vibrates and turns green, and the cap's ring changes from yellow to magenta.

10 sec

UV-C applied to the connector septum

4-log

Reduction of S. aureus, K. pneumoniae, S. epidermidis and E. cloacae with a 5-second CHG/IPA wipe*

7 days

Physical barrier against environmental contamination if the cap is not removed

*Under the conditions of in vitro testing. Not shown to significantly reduce fungal organisms. A correlation to clinical infection-related outcomes has not been established. Review the evidence

Let's make every line safer.

Schedule a trial evaluation, or request samples and clinical materials.